---
figid: PMC3983565__nihms570991f4
figlink: /pmc/articles/PMC3983565/figure/F4/
number: F4
caption: 'MAPK signalling cooperates with loss of APC to promote adenoma development.
  The tumour suppressive function of APC lies in its ability to bind β-catenin, leading
  to phosphorylation of β-catenin by GSK3β and its subsequent degradation. Activation
  of the MAPK/ERK pathway can mediate β-catenin stabilization through ERK-mediated
  inhibition of GSK3β. Stabilized β-catenin primarily mediates its oncogenic effects
  through transcriptional activation of target genes such as MYC. Pro-oncogenic MYC
  is vital for APC-mediated tumorigenesis. ERK can further drive tumour formation
  in the context of APC loss by stabilizing Myc though post-translational modifications.
  Abbreviations: MEK, mitogen-activated protein kinase kinase; ERK, extracellular
  signal-regulated kinase; EGFR, epidermal growth factor receptor; APC, adenomatous
  polyposis coli; GSK3β, Glycogen synthase kinase-3 beta; Axin, axis inhibition protein.'
pmcid: PMC3983565
papertitle: Paradoxical oncogenesis and the long term consequences of BRAF inhibition
  in melanoma.
reftext: Geoffrey T. Gibney, et al. Nat Rev Clin Oncol. ;10(7):390-399.
pmc_ranked_result_index: '94622'
pathway_score: 0.9748743
filename: nihms570991f4.jpg
figtitle: MAPK signalling cooperates with loss of APC to promote adenoma development
year: ''
organisms: Homo sapiens
ndex: 845049eb-dec1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3983565__nihms570991f4.html
  '@type': Dataset
  description: 'MAPK signalling cooperates with loss of APC to promote adenoma development.
    The tumour suppressive function of APC lies in its ability to bind β-catenin,
    leading to phosphorylation of β-catenin by GSK3β and its subsequent degradation.
    Activation of the MAPK/ERK pathway can mediate β-catenin stabilization through
    ERK-mediated inhibition of GSK3β. Stabilized β-catenin primarily mediates its
    oncogenic effects through transcriptional activation of target genes such as MYC.
    Pro-oncogenic MYC is vital for APC-mediated tumorigenesis. ERK can further drive
    tumour formation in the context of APC loss by stabilizing Myc though post-translational
    modifications. Abbreviations: MEK, mitogen-activated protein kinase kinase; ERK,
    extracellular signal-regulated kinase; EGFR, epidermal growth factor receptor;
    APC, adenomatous polyposis coli; GSK3β, Glycogen synthase kinase-3 beta; Axin,
    axis inhibition protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - WNT11
  - AXIN2
  - APC
  - MAPK9
  - MAPK10
  - CCND1
  - WNT5A
  - WNT8A
  - WNT8B
  - WNT10B
  - WNT7B
  - MAPK11
  - WNT2
  - MYC
  - AXIN1
  - WNT7A
  - EGFR
  - HRAS
  - WNT6
  - NRAS
  - WNT2B
  - CTNNB1
  - KRAS
  - WNT3
  - WNT1
  - BMF
  - WNT10A
  - WNT3A
  - MAPK13
  - MAPK12
  - MAP2K1
  - MAP2K2
  - WNT9A
  - BCL2L11
  - GSK3B
  - MAPK14
  - WNT5B
  - MAPK1
  - WNT4
  - MAPK3
  - WNT16
  - WNT9B
  - MAPK8
  - Cancer
genes:
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: (cMyc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: B-Catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: BMF
  symbol: BMF
  source: hgnc_symbol
  hgnc_symbol: BMF
  entrez: '90427'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3983565__F4
redirect_from: /figures/PMC3983565__F4
figtype: Figure
---
